VOLUME 2 INDEX
VOLUME
2, NUMBER 12 3/4/03
- Counterfeit Drugs in China: Shanghai Steps Up Drug Monitoring
Systems
- Promoting Taiwan's Medical Equipment Market in the International
Arena
- Singapore Launches Standardization for Medical Devices
- Effects of Genome-Based Medicine on Japanese Medical Regulation
VOLUME
2, NUMBER 11 2/4/03
- New Good Laboratory Practice Announced by Japan's Ministry
of Health, Labor and Welfare
- Singapore: A Prime Location for Biotechnology Companies
- Contract Manufacturing of Medical Devices in Asia
- Memorandum of Understanding Signed by Singapore and China Will
Simplify Product Certification in Both Countries
VOLUME
2, NUMBER 10 1/6/03
- Keeping Shonins Up-To-Date and Partial Amendments
- Disputes Continue Between Foreign Pharmaceutical Manufacturers
and the Korean Authorities
- Economic Stagnation and the Relaxing of Pharmaceutical Regulations
in Japan
- An Update on Malaysia's Medical Device Market
VOLUME
2, NUMBER 9 12/10/02
- Japan: Informed Consent and Clinical Trials
- China: New SDA Regulations for Drug Product Registration
- South Korea Bans Human Cloning and Stem Cell Research
- Drug Retailers in China Prepare for Foreign Competition
VOLUME
2, NUMBER 8 11/4/02
- Patient Disclosure and Clinical Trials in Japan
- The Growing China OTC Market
- Korea's Proposed "Medical Devices Act"
- Proposed Lifting of Goods and Services Tax for Healthcare in Singapore
- Mergers of Japanese Pharmaceutical Companies with Foreign
Multinationals
VOLUME
2, NUMBER 7 10/2/02
- Japanese Health Insurance Reform Bill
- China Considers Tax Breaks to Encourage Drug Development
- Foreigners-Only Hospitals in South Korea's SEZs
- Building a Virtual Drug Development Laboratory in Japan
- More Stringent Regulations on Chinese Proprietary Medicines in Singapore
VOLUME
2, NUMBER 6 9/3/02
- South Korea's Drug Pricing Controversy
- Revision of the Japanese Pharmaceutical Affairs Law
- The China Compulsory Certification: A new safety certification
- Singapore Government Promotes Growth of Local Biomedical
Companies
VOLUME
2, NUMBER 5 8/2/02
- Japan's New Pharmaceutical Law: New rules to dismantle ICC
system
- Biomedical Research Advances in Singapore: Government announces
liberal regulations for stem cell research
- Product Standards and Labeling Requirements for Pharmaceuticals
in India: An overview
- Traditional Chinese Medicine: Demand growing, product quality
improving both East and West
VOLUME
2, NUMBER 4 7/8/02
- Growth of Biotechnology in Asia
- Changes in the Singapore Medical Device Regulatory System
- Bypassing Local Testing for Medical Devices in Korea
- Drug Testing in China
VOLUME
2, NUMBER 3 6/10/02
- India's Pharmaceutical Industry: An overview
- The Drug Control Authority of Malaysia: Pharmaceutical Regulatory
Regime Examined
- Japan's Acceptance of Foreign Clinical Data: Progress remains
slow
- Japan's Ministry of Health, Labor, and Welfare: An overview
- Trade Mission to China: U.S. medical device firms may benefit
from participation in government program
VOLUME
2, NUMBER 2 5/6/02
- Pharmaceutical Industry Reform in China: New Drug Administrative
Law
- Drug Pricing Reform in Japan: Reimbursement prices slashed
- Medical Devices in Japan: Standards and guidelines for GCP
and clinical trials
- Singapore's Biotech Industry: Government plays a major role
VOLUME
2, NUMBER 1 4/2/02
- Korea's Pharmaceutical Market: New developments helpful
for foreign firms
- Biotechnology in Taiwan: Creating a vibrant domestic industry
- China's Pharmaceutical Market: Opportunities and challenges
- Medical Equipment in Vietnam: Market entry and distribution
Vol. 8 | Vol. 7 | Vol.6 | Vol.5 | Vol.4 | Vol.3 | Vol. 2 | Vol. 1
Back to Top
